Zjisti víc
377 - Ep. 367 - FDA, obesity targets and the rise of DACs
00:00
00:00
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Epizody
377-
Ep. 367 - FDA, obesity targets and the rise of DACs
Přehrané
376-
Ep. 366 - Europe's need for speed: Bio€quity takeaways
Přehrané
375-
Ep. 365 - Thin ice for Makary, redosing AAVs
Přehrané
374-
Ep. 364 - UCB’s Candid buy, Grand Rounds and leukodystrophies
Přehrané
373-
